BARBONI, CATIA
BARBONI, CATIA
DIPARTIMENTO DI SCIENZE MEDICHE VETERINARIE
Personale tecnico amm.vo
Decrease in Heparan Sulphate Binding in Tropism-Retargeted Oncolytic Herpes Simplex Virus (ReHV) Delays Blood Clearance and Improves Systemic Anticancer Efficacy
2024 Vannini A.; Parenti F.; Forghieri C.; Vannini G.; Barboni C.; Zaghini A.; Gianni T.; Campadelli-Fiume G.
Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice
2023 ANDREA VANNINI; Federico Parenti; CATIA BARBONI; Cristina Forghieri; Valerio Leoni; Mara Sanapo; Daniela Bressanin; anna zaghini; Gabriella Campadelli-Fiume; Tatiana Gianni
Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers
2023 Vannini A.; Parenti F.; Forghieri C.; Barboni C.; Zaghini A.; Campadelli-Fiume G.; Gianni T.
Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV
2021 Gianni T.; Leoni V.; Sanapo M.; Parenti F.; Bressanin D.; Barboni C.; Zaghini A.; Campadelli-Fiume G.; Vannini A.
Immunotherapeutic efficacy of retargeted ohsvs designed for propagation in an ad hoc cell line
2021 Vannini A.; Leoni V.; Sanapo M.; Gianni T.; Giordani G.; Gatta V.; Barboni C.; Zaghini A.; Campadelli-fiume G.
Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice
2021 Squarzoni S.; Schena E.; Sabatelli P.; Mattioli E.; Capanni C.; Cenni V.; D'Apice M.R.; Andrenacci D.; Sarli G.; Pellegrino V.; Festa A.; Baruffaldi F.; Storci G.; Bonafé M.; Barboni C.; Sanapo M.; Zaghini A.; Lattanzi G.
Towards a precision medicine approach and in situ vaccination against prostate cancer by psma-retargeted ohsv
2021 Vannini A.; Parenti F.; Bressanin D.; Barboni C.; Zaghini A.; Campadelli-Fiume G.; Gianni T.
Long term breeding of the Lmna G609G progeric mouse: Characterization of homozygous and heterozygous models
2020 Zaghini A.; Sarli G.; Barboni C.; Sanapo M.; Pellegrino V.; Diana A.; Linta N.; Rambaldi J.; D'Apice M.R.; Murdocca M.; Baleani M.; Baruffaldi F.; Fognani R.; Mecca R.; Festa A.; Papparella S.; Paciello O.; Prisco F.; Capanni C.; Loi M.; Schena E.; Lattanzi G.; Squarzoni S.
αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion
2019 Vannini A.; Leoni V.; Barboni C.; Sanapo M.; Zaghini A.; Malatesta P.; Campadelli-Fiume G.; Gianni T.
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
2018 Leoni, Valerio; Vannini, Andrea; Gatta, Valentina; Rambaldi, Julie; Sanapo, Mara; Barboni, Catia; Zaghini, Anna; Nanni, Patrizia; Lollini, Pier-Luigi; Casiraghi, Costanza; Campadelli-Fiume, Gabriella
Immunocompetent C57BL/6 mouse, engineered to be tolerant to the human HER2 receptor, as a model for the study of retargeted fully-virulent oncolytic Herpes Virus (HSV)
2018 Sanapo M., Barboni C., Campadelli-Fiume MG, Mazza F, Leoni V, Zaghini A
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Decrease in Heparan Sulphate Binding in Tropism-Retargeted Oncolytic Herpes Simplex Virus (ReHV) Delays Blood Clearance and Improves Systemic Anticancer Efficacy | Vannini A.; Parenti F.; Forghieri C.; Vannini G.; Barboni C.; Zaghini A.; Gianni T.; Campadelli-F...iume G. | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | Vannini_2024.pdf; cancers-16-01143-s001.zip |
| Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice | ANDREA VANNINI; Federico Parenti; CATIA BARBONI; Cristina Forghieri; Valerio Leoni; Mara Sanapo; ...Daniela Bressanin; anna zaghini; Gabriella Campadelli-Fiume; Tatiana Gianni | 2023-01-01 | CANCERS | - | 1.01 Articolo in rivista | ONCOLITICI cancers-15-04042.pdf |
| Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers | Vannini A.; Parenti F.; Forghieri C.; Barboni C.; Zaghini A.; Campadelli-Fiume G.; Gianni T. | 2023-01-01 | FRONTIERS IN MOLECULAR BIOSCIENCES | - | 1.01 Articolo in rivista | ONCOLITICI maggio 2023 fmolb-10-1149973.pdf |
| Genotype of Immunologically Hot or Cold Tumors Determines the Antitumor Immune Response and Efficacy by Fully Virulent Retargeted oHSV | Gianni T.; Leoni V.; Sanapo M.; Parenti F.; Bressanin D.; Barboni C.; Zaghini A.; Campadelli-Fium...e G.; Vannini A. | 2021-01-01 | VIRUSES | - | 1.01 Articolo in rivista | viruses-13-01747.pdf; viruses-13-01747-s001.zip |
| Immunotherapeutic efficacy of retargeted ohsvs designed for propagation in an ad hoc cell line | Vannini A.; Leoni V.; Sanapo M.; Gianni T.; Giordani G.; Gatta V.; Barboni C.; Zaghini A.; Campad...elli-fiume G. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-13-00266.pdf |
| Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice | Squarzoni S.; Schena E.; Sabatelli P.; Mattioli E.; Capanni C.; Cenni V.; D'Apice M.R.; Andrenacc...i D.; Sarli G.; Pellegrino V.; Festa A.; Baruffaldi F.; Storci G.; Bonafé M.; Barboni C.; Sanapo M.; Zaghini A.; Lattanzi G. | 2021-01-01 | AGING CELL | - | 1.01 Articolo in rivista | IL6-AgingCell.pdf |
| Towards a precision medicine approach and in situ vaccination against prostate cancer by psma-retargeted ohsv | Vannini A.; Parenti F.; Bressanin D.; Barboni C.; Zaghini A.; Campadelli-Fiume G.; Gianni T. | 2021-01-01 | VIRUSES | - | 1.01 Articolo in rivista | viruses-13-02085.pdf |
| Long term breeding of the Lmna G609G progeric mouse: Characterization of homozygous and heterozygous models | Zaghini A.; Sarli G.; Barboni C.; Sanapo M.; Pellegrino V.; Diana A.; Linta N.; Rambaldi J.; D'Ap...ice M.R.; Murdocca M.; Baleani M.; Baruffaldi F.; Fognani R.; Mecca R.; Festa A.; Papparella S.; Paciello O.; Prisco F.; Capanni C.; Loi M.; Schena E.; Lattanzi G.; Squarzoni S. | 2020-01-01 | EXPERIMENTAL GERONTOLOGY | - | 1.01 Articolo in rivista | Progerie - lavoro colonie.pdf |
| αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion | Vannini A.; Leoni V.; Barboni C.; Sanapo M.; Zaghini A.; Malatesta P.; Campadelli-Fiume G.; Giann...i T. | 2019-01-01 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - | 1.01 Articolo in rivista | 20141.full.pdf |
| A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors | Leoni, Valerio; Vannini, Andrea; Gatta, Valentina; Rambaldi, Julie; Sanapo, Mara; Barboni, Catia;... Zaghini, Anna; Nanni, Patrizia; Lollini, Pier-Luigi; Casiraghi, Costanza; Campadelli-Fiume, Gabriella | 2018-01-01 | PLOS PATHOGENS | - | 1.01 Articolo in rivista | HSV IL-12 PLoS Pathog 2018.pdf |
| Immunocompetent C57BL/6 mouse, engineered to be tolerant to the human HER2 receptor, as a model for the study of retargeted fully-virulent oncolytic Herpes Virus (HSV) | Sanapo M., Barboni C., Campadelli-Fiume MG, Mazza F, Leoni V, Zaghini A | 2018-01-01 | - | - | 4.03 Poster | - |